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Dao.  Results: Forty-nine infants were included, with a me-
dian GA of 27.6 weeks (IQR: 26.1–29.0), birth weight of
980 g (IQR: 800–1,200), and postnatal age of 77 h (IQR: 70–
107). Infants with a closed duct (n = 11), a non-HSDA (n = 
18), and an HSDA (n = 20) had similar cerebral and renal 
NIRS measurements. Retrograde diastolic blood flow in the 
Dao, present in 11 infants with PDA, also did not affect ce-
rebral and renal NIRS measurements.  Conclusion: In pre-
term infants with clinical signs of an HSDA within 2 weeks 
after birth, cerebral and renal oxygen saturation and ex-
traction are not affected by an HSDA or by retrograde dia-
stolic blood flow in the Dao.  © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 Patent ductus arteriosus (PDA) is a common finding 
in preterm infants. In the presence of a large PDA and 
decreasing pulmonary-to-systemic vascular resistance 
ratio, significant systemic to pulmonary shunting occurs, 
which results in pulmonary hyperperfusion and systemic 
hypoperfusion. Although causality has not yet been prov-
en sufficiently, persistent patency of the ductus arteriosus 
 Key Words 
 Near-infrared spectroscopy · Echocardiography · Patent 
ductus arteriosus · Preterm infants · Tissue oxygenation 
 Abstract 
 Background: Patent ductus arteriosus (PDA) is common in 
preterm infants and is associated with significant morbid-
ity. To determine whether the PDA is hemodynamically
significant (HSDA), several echocardiographic parameters 
have been suggested, including retrograde diastolic blood 
flow in the descending aorta (Dao).  Objective: To assess 
the impact of  an HSDA, including retrograde diastolic flow 
in the Dao, on regional tissue oxygen saturation (rSO 2 ) and 
extraction measured by near-infrared spectroscopy (NIRS). 
 Methods: This is a prospective observational cohort study 
in which we included preterm infants (GA <32 weeks) who 
underwent echocardiographic screening because of clini-
cal signs of an HSDA within 2 weeks after birth. We mea-
sured cerebral and renal rSO 2 on the day of echocardiogra-
phy. HSDA was diagnosed if left-to-right shunting through 
the PDA was accompanied by left atrial-to-aortic root ratio 
>1.4 and/or left pulmonary artery end-diastolic flow veloc-
ity >0.2 m/s and/or retrograde diastolic blood flow in the 
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(DA) in preterm infants has been associated with signifi-
cant morbidities such as intraventricular hemorrhage, 
necrotizing enterocolitis, and renal insufficiency, possi-
bly due to decreased systemic blood flow resulting in tis-
sue ischemia  [1–4] . 
 Whether a PDA will impact organ tissue oxygen sup-
ply may depend on its hemodynamic significance. How-
ever, no consensus exists concerning the echocardio-
graphic definition of a hemodynamically significant PDA 
(HSDA). The size of the DA and the direction of shunting 
through the DA have been used as treatment criteria but 
may not accurately quantify the transductal shunt. Echo-
cardiographic parameters believed to better reflect the 
circulatory consequences of an HSDA include the pres-
ence of increased antegrade diastolic blood flow in the left 
pulmonary artery (LPA), an increased left atrial-to-aortic 
root (LA:Ao) ratio, and the presence of ductal steal asso-
ciated with retrograde diastolic blood flow in the de-
scending aorta (Dao)  [5] . Previous studies have demon-
strated that these parameters reflect large transductal 
shunt volumes  [6, 7] . Whether such shunt leads to de-
creased pre- or postductal organ tissue oxygen supply in 
preterm infants remains unclear.
 Near-infrared spectroscopy (NIRS) is a noninvasive 
tool with which the regional tissue oxygen saturation 
(rSO 2 ) of the underlying tissue can be measured. When 
transcutaneous arterial oxygen saturation (spO 2 ) is mea-
sured simultaneously, fractional tissue oxygen extraction 
(FTOE) can be calculated, which reflects the balance be-
tween tissue oxygen delivery and tissue oxygen consump-
tion  [8] . In the presence of constant tissue oxygen me-
tabolism, FTOE reflects tissue perfusion. 
 Previous studies using NIRS to assess organ oxygen-
ation in preterm infants with PDA used different criteria 
for the determination of an HSDA and found conflicting 
results concerning the impact of PDA on pre- and post-
ductal organ oxygenation  [9–12] . The specific impact of 
echocardiographic parameters of hemodynamic signifi-
cance of a PDA on regional tissue oxygen supply has not 
been investigated previously. 
 Our first aim, therefore, was to assess whether upper 
and lower organ tissue oxygen delivery, as reflected by 
cerebral and renal rSO 2 and FTOE, is affected in infants 
with an HSDA compared with infants with a non-HSDA 
and infants with a closed DA. Our second aim was to as-
sess the impact of separate echocardiographic parameters 
of supposed hemodynamic significance, particularly ret-
rograde diastolic blood flow in the Dao as a marker for 
ductal steal, on cerebral and renal rSO 2 and FTOE in in-
fants with PDA. 
 Methods 
 Patients 
 We included patients from two simultaneous prospective ob-
servational cohort studies conducted at the neonatal intensive care 
unit of University Medical Center Groningen between February 
2012 and March 2014. In both, preterm infants (GA <32 weeks) 
who underwent echocardiographic screening for a PDA during the 
first 2 weeks after birth were eligible for inclusion. Infants with 
cardiovascular defects other than a PDA, with other major con-
genital defects or with persistent pulmonary hypertension of the 
newborn were excluded. Depending on the study in which the pa-
tient was included, NIRS was measured either continuously or for 
2 h daily. The studies were approved by the ethics review board of 
University Medical Center Groningen. Written informed parental 
consent was obtained in all cases.
 Echocardiography 
 Screening echocardiography was routinely performed in all in-
fants who still required mechanical ventilation or continuous pos-
itive airway pressure on the third postnatal day. Furthermore, 
echocardiography was performed when an HSDA was otherwise 
suspected clinically (continuing respiratory distress, unexplained 
need for supplemental oxygen, metabolic acidosis, bounding puls-
es and/or increased pulse pressure). Echocardiograms were made 
by the attending pediatric cardiologist or a trained pediatric ultra-
sonographist, using a Vivid-I ultrasound scanner (GE Healthcare, 
UK) with a 10-MHz probe. 
 A PDA was classified as hemodynamically significant when a 
DA was present with predominantly left-to-right shunting across 
the DA associated with (1) LA:Ao ratio >1.4 and/or (2) end-dia-
stolic blood flow velocity in the LPA >0.2 m/s and/or (3) diastolic 
flow reversal in the Dao. 
 Ductal flow recordings were made from a high parasternal view 
using continuous-wave Doppler. The LA:Ao ratio was measured 
using M-Mode pictures from the parasternal long axis view using 
the leading-edge-to-leading-edge technique. End-diastolic flow 
velocity in the LPA and postductal flow velocity in the Dao were 
measured using pulsed-wave Doppler from a high parasternal 
view. Furthermore, we measured the internal ductal diameter, the 
left ventricular end-diastolic diameter, fractional shortening, and 
ejection fraction. The ductal diameter was measured during end-
systole at the point of maximum constriction using color Doppler 
flow, with care taken to minimalize color gain to avoid color inter-
ference outside of the vessel wall. The left ventricular end-diastol-
ic diameter, fractional shortening, and ejection fraction were mea-
sured using M-Mode pictures from the parasternal long axis view. 
Echocardiograms were stored for off-line analysis and were ana-
lyzed as a batch by a trained researcher (M.E.v.d.L.) who was blind-
ed to the NIRS data.
 Multisite NIRS Measurements 
 We used the INVOS 5100C near-infrared spectrometer and 
neonatal SomaSensors (Covidien, Mansfield, Mass., USA) to mea-
sure cerebral and renal rSO 2 (r c SO 2 and r r SO 2 ) on the day of echo-
cardiography. Sensors were placed on the frontoparietal side of the 
infant’s head (r c SO 2 ) and on the lateral posterior flank (r r SO 2 ). 
 NIRS data were stored for off-line analysis. We calculated 
FTOE for each location as: FTOE = (spO 2 – rSO 2 )/spO 2 . As ductal 









































Demographic and clinical characteristics
Gestational age, week s 28.0 (26.0 – 28.9) 27.6 (26.2 – 28.7) 26.7 (26.0 – 29.3) n.s.
Birth weight, g 900 (800 – 1,260) 985 (788 – 1,200) 1,005 (785 – 1,250) n.s.
Apgar score at 5 min 7 (7 – 8) 8 (6 – 8)
n = 17
7 (6 – 8) n.s.
Postnatal age at inclusion, h 80 (70 – 125) 90 (74 – 104) 71 (65 – 105) n.s.















Mean airway pressure, mm Hg 9.0 (5.3 – 11.3) 8.5 (6.2 – 10.9) 11.2 (6.4 – 12.4) n.s.
Inspired oxygen 0.25 (0.21 – 0.33) 0.24 (0.21 – 0.31) 0.24 (0.21 – 0.30) n.s.
Hb, mmol/l 8.7 (8.2 – 9.0) 8.5 (7.8 – 8.9)
n = 17
8.4 (7.8 – 9.9)
n = 19
n.s.
pCO2, kPa 5.7 (4.9 – 6.8)
n = 10
6.4 (5.5 – 7.1)
n = 17
5.9 (5.3 – 6.9)
n = 18
n.s.
Inotropes 2 (18) 0 (0) 2 (10) n.s.
Heart rate, bpm 155 (149 – 161) 152 (150 – 157) 155 (150 – 166) n.s.
Systolic blood pressure, mm Hg 53 (45 – 60) 52 (45 – 60)
n = 16
49 (41 – 57) n.s.
Mean blood pressure, mm Hg 38 (34 – 46) 39 (33 – 43)
n = 16
34 (30 – 40) n.s.
Diastolic blood pressure, mm Hg 29 (25 – 37) 29 (26 – 34)
n = 16
24 (22 – 32) n.s.
Urine output, ml/kg/h 3.2 (2.7 – 6.0) 4.8 (2.8 – 5.9) 4.1 (3.1 – 5.3) n.s.
Echocardiographic characteristics
LVEF, % 74 (66–84) 79 (75 – 87)
n = 16
78 (74 – 82)
n = 18
n.s.
LVFS, % 36 (30–45) 43 (35 – 49)
n = 17
39 (36 – 43)
n = 18
n.s.
Ductal diameter, mm – 1.5 (0.7 – 1.6)
n = 14
2.2 (1.7 – 2.5)
n = 19
0.003
LA:Ao ratio – 1.2 (1.1 – 1.2)
n = 14
1.5 (1.2 – 1.6)
n = 18
0.009
End-diastolic velocity in LPA, m/s – 0.10 (0.07 – 0.12)
n = 17
0.23 (0.17 – 0.26)
n = 17
<0.001
EDFv/SFv DA – 0.65 (0.39 – 0.77)
n = 13
0.36 (0.27 – 0.53)
n = 17
0.035
NIRS and spO2 measurements
cFTOE 0.22 (0.11 – 0.33) 0.22 (0.18 – 0.29) 0.19 (0.09 – 0.25) n.s.
rFTOE 0.25 (0.21 – 0.39) 0.39 (0.26 – 0.50) 0.32 (0.23 – 0.50)
n = 18
n.s.
rcSO2, % 76 (64 – 77) 70 (64 – 74) 75 (68 – 82) n.s.
rrSO2, % 66 (56 – 75) 55 (44 – 66) 62 (45 – 74) n.s.
CROR 0.92 (0.86 – 0.99) 0.79 (0.63 – 0.87) 0.81 (0.63 – 0.96)
n = 18
n.s.
spO2, % 95 (89 – 97) 89 (87 – 93) 90 (89 – 97) n.s.
 Data are presented as medians (IQR) or n (%), as appropriate. SIMV = Synchronized intermittent mechanical ventilation; HFOV = 
high frequency oscillatory ventilation; CPAP = continuous positive airway pressure; NIMV = nasal intermittent mechanical ventilation; 
LF = low flow; LVEF = left ventricular ejection fraction; LVFS = left ventricular fractional shortening; EDFv = end-diastolic flow veloc-
































13–15] , we also calculated the cerebrorenal oxygenation ratio 
(CROR) as CROR = r r SO 2 /r c SO 2 . 
 Mean 1-hour values of r c SO 2 , r r SO 2 , cerebral and renal FTOE, 
and CROR were calculated within 3 h preceding or following each 
echocardiogram, depending on the stability of the NIRS data. If 
NIRS parameters were not available within these 3 h and the echo-
cardiogram showed a PDA, we did not include this particular in-
fant in the present study. If the echocardiogram showed a closed 
DA, we assumed that the DA remained closed for the next 24 h and 
included the infant if stable measurements during 1 h were avail-
able within 24 h following echocardiography. NIRS data were cat-
egorized as unreliable and excluded from analyses in the case of 
documented malplacement of sensors and in the case of baseline 
changes >50% after the documented replacement of sensors.
 Demographic and Clinical Variables 
 We prospectively collected clinical characteristics on the day of 
echocardiography including heart rate, blood pressure, urine out-
put, spO 2 , pCO 2, and hemoglobin levels. We also collected GA, birth 
weight, Apgar score, postnatal age, weight, ventilator mode and set-
tings, and inotrope administration from the patients’ medical charts. 
 Statistical Analysis 
 First, we classified all included infants into three groups: infants 
with a closed DA, infants with a non-HSDA, and infants with an 
HSDA. Second, we classified all infants with PDA into infants with 
retrograde diastolic blood flow in the Dao and infants without ret-
rograde diastolic blood flow in the Dao. Differences in clinical char-
acteristics, echo parameters, and NIRS measurements between 
groups were tested with the Kruskal-Wallis test and the Mann-
Whitney test for continuous data and the χ 2 test for categorical data, 
where appropriate. Spearman’s correlation coefficients were calcu-
lated to assess the association between echo parameters of ductal 
hemodynamic significance and NIRS measurements in all infants 
with PDA. SPSS 22.0 (IBM Corp., Armonk, N.Y., USA) was used for 
all statistical analyses. A p value <0.05 was considered significant. 
 Results 
 We enrolled 57 infants, of whom 8 were excluded from 
further analysis due to poor NIRS signal integrity (n = 4), 
inability to reliably classify the hemodynamic signifi-
cance of the DA due to incomplete echocardiography
(n = 3), and the presence of a ventricular septum defect 
(n = 1). The remaining 49 infants had a median GA of 
27.6 weeks (IQR: 26.1–29.0), a median birth weight of
980 g (IQR: 800–1,200), and a median postnatal age at the 
time of echocardiography of 77 h (IQR: 70–107). Patient 
and clinical characteristics of the 8 excluded infants did 
not differ from those of the study group. 
 Eleven infants had a closed DA. Of the 38 infants with 
PDA, 20 had an HSDA. Demographic and clinical charac-
teristics did not differ between the three groups ( table 1 ). 
Echocardiographic characteristics are also presented. 
Ducts were larger in infants with an HSDA compared with 
infants with a non-HSDA: median 2.2 mm (IQR: 1.7–2.5) 
versus 1.5 mm (IQR: 0.7–1.6), p = 0.003. NIRS measure-
ments did not differ between the three groups ( table 1 ).
 Retrograde Diastolic Blood Flow in the Dao 
 Of the 38 infants with PDA, echocardiography re-
vealed retrograde diastolic blood flow in the Dao in 11, 
whereas this was absent in 21 infants; in 6 infants, dia-
stolic blood flow in the Dao could not reliably be eval-
uated due to poor signal discrimination. Clinical and
patient characteristics did not differ between groups
( table 2 ). Echocardiographic characteristics are also pre-
sented. NIRS measurements did not differ between in-
fants with and infants without retrograde diastolic blood 
flow in the Dao ( table 2 ). 
 Correlation between Echocardiographic Parameters 
and NIRS Measurements 
 Spearman’s correlation coefficients between echocar-
diographic parameters of hemodynamic significance and 
NIRS measurements are presented in  table  3 . End-dia-
stolic velocity in the LPA correlated significantly with re-
nal FTOE (rho: –0.418, p = 0.017) and rSO 2 (rho: 0.438, 
p = 0.012), but not with cerebral NIRS measurements. 
 Discussion 
 This study demonstrated that, in preterm infants with 
clinical signs of PDA during the first 2 weeks after birth, 
cerebral and renal oxygen saturation and extraction were 
not affected by the presence of a PDA, whether or not it 
was echocardiographically classified as hemodynamically 
significant. Furthermore, we demonstrated that in the 
presence of a PDA, cerebral and renal rSO 2 and FTOE 
were not compromised by retrograde diastolic blood flow 
in the Dao. Other echocardiographic signs suggestive of 
an HSDA, such as increased ductal diameter, increased 
end-diastolic blood flow velocity in the LPA and in-
creased LA:Ao ratio, were also not associated with im-
paired cerebral or renal NIRS measurements. 
 Echocardiographic signs used to classify a PDA as he-
modynamically significant or not have previously all been 
related to large transductal shunt volumes  [6, 7] . Still, we 
found no effect of the presence of an HSDA on cerebral 
or renal rSO 2 and FTOE, and no significant associations 
between independent echocardiographic signs suggest-
ing an HSDA and impaired cerebral and renal oxygen 
saturation and extraction. Our results suggest that, in the 
































 Table 2.  Demographic, clinical and echocardiographic characteristics of infants with and without retrograde diastolic blood flow in the 
Dao, and NIRS and spO2 measurements
No retrograde






Demographic and clinical characteristics
Gestational age, weeks 26.7 (26.0 – 28.8) 26.9 (26.1 – 29.9) n.s.
Birth weight, g 990 (790 – 1,155) 1,025 (670 – 1,300) n.s.
Apgar score at 5 min 7 (6 – 8)
n = 20
7 (6 – 8) n.s.
Postnatal age at inclusion, h 77 (71 – 102) 70 (61 – 106) n.s.











Mean airway pressure, mm Hg 8.3 (6.2 – 11.2) 12.0 (6.0 – 12.8) n.s.
Inspired oxygen 0.24 (0.21 – 0.27) 0.24 (0.21 – 0.30) n.s.
Hb, mmol/l 8.6 (7.9 – 9.7) 8.3 (8.0 – 10.8) 
n = 10
n.s.
pCO2, kPa 6.0 (5.2 – 6.6)
n = 20
6.7 (5.4 – 7.2)
n = 10
n.s.
Inotropes 1 (5) 1 (8) n.s.
Heart rate, bpm 154 (151 – 158) 152 (149 – 165) n.s.
Systolic blood pressure, mm Hg 48 (45 – 60) 50 (46 – 65) n.s.
Mean blood pressure, mm Hg 34 (32 – 43) 38 (34 – 41) n.s.
Diastolic blood pressure, mm Hg 26 (23 – 30) 27 (21 – 33) n.s.
Urine output, ml/kg/h 4.5 (3.2 – 5.8) 3.2 (2.2 – 5.4) n.s.
Echocardiographic characteristics
LVEF, % 79 (73 – 84)
n = 18
77 (75 – 81) n.s.
LVFS, % 41 (35 – 47)
n = 18
39 (37 – 42) n.s.
Ductal diameter, mm 1.4 (1.0 – 1.7)
n = 17
2.3 (2.1 – 2.6)
n = 10
0.003
LA:Ao ratio 1.2 (1.1 – 1.3)
n = 17
1.4 (1.1 – 1.6)
n = 10
n.s.
End-diastolic velocity in LPA, m/s 0.12 (0.07 – 0.16)
n = 19
0.25 (0.17 – 0.33)
n = 10
<0.001
EDFv/SFv DA 0.64 (0.47 – 0.78)
n = 14
0.35 (0.26 – 0.47)
n = 10
0.018
NIRS and spO2 measurements
cFTOE 0.22 (0.16 – 0.29) 0.19 (0.08 – 0.23) n.s.
rFTOE 0.40 (0.27 – 0.55) 0.33 (0.23 – 0.44)
n = 9
n.s.
rcSO2, % 69 (66 – 76) 76 (69 – 82) n.s.
rrSO2, % 54 (43 – 66) 58 (50 – 75)
n = 9
n.s.
CROR 0.77 (0.58 – 0.88) 0.85 (0.64 – 0.98)
n = 9
n.s.
spO2, % 90 (87 – 94) 90 (89 – 96) n.s.
 Data are presented as medians (IQR) or n (%), as appropriate. SIMV = Synchronized intermittent mechanical ventilation; HFOV = 
high frequency oscillatory ventilation; CPAP = continuous positive airway pressure; NIMV = nasal intermittent mechanical ventilation; 
LF = low flow; LVEF = left ventricular ejection fraction; LVFS = left ventricular fractional shortening; EDFv = end-diastolic flow veloc-
































cerebral and renal oxygen delivery is not compromised. 
Our results are in line with previous studies reporting 
similar cerebral  [9] and renal  [10] rSO 2 and FTOE in pre-
term infants with an HSDA compared with infants with 
a closed DA. They are also in line with a study reporting 
similar cerebral and renal rSO 2 and FTOE in infants with 
large-sized ducts compared with infants with moderate-
sized ducts  [11] . 
 Conversely, Lemmers et al.  [12] reported decreased ce-
rebral rSO 2 in infants with an HSDA compared with 
matched controls without clinical signs of a PDA. In this 
study, however, infants with an HSDA received inotropes 
more often than controls. Dopamine administration has 
previously been associated with impaired cerebrovascu-
lar autoregulation in preterm infants  [16] and a mismatch 
between cerebral perfusion and oxygenation in newborn 
piglets  [17] . We speculate that the higher rate of admin-
istration of dopamine might have contributed to their 
findings of decreased cerebral rSO 2 in the presence of an 
HSDA, in contrast to all previous reports. In our cohort, 
only few infants received blood pressure support using 
inotropes.
 In preterm infants with an HSDA, alterations in dia-
stolic blood flow in several major arteries have been de-
scribed, including the Dao, middle cerebral artery, renal 
artery, and superior mesenteric artery  [15, 18] . The rela-
tionship, however, between these echocardiographic 
markers of ductal steal, actual end-organ tissue oxygen 
delivery, and adverse outcome remains unclear  [19] . 
Groves et al.  [13] reported preserved superior vena cava 
flow but decreased Dao flow in preterm infants with PDA 
and retrograde diastolic blood flow in the Dao compared 
with infants with PDA without retrograde diastolic blood 
flow in the Dao during the first 48 h after birth. We did 
not find an effect of retrograde diastolic blood flow on 
cerebral or renal oxygen saturation and extraction. The 
results of the current study suggest that, at least on group 
level, cerebral as well as renal tissue oxygen delivery are 
preserved in the presence of retrograde diastolic blood 
flow in the Dao in preterm infants with postnatal age
>48 h during the first 2 weeks after birth. 
 We recognize several limitations of our study. First, as 
we only included infants who underwent echocardiogra-
phy mostly after the transitional period, but not after the 
first 2 weeks after birth, our results cannot be extrapo-
lated to younger or older infants. Second, a failure to find 
any differences between groups might be due to the cri-
teria for HSDA that we used, which are not generally 
agreed upon. Third, concerns have been raised concern-
ing the accuracy and precision of cerebral NIRS monitor-
ing. Previous studies have described a high replacement 
variability with limits of agreement of up to 18%  [20–22] . 
Furthermore, while cerebral oximetry has extensively 
been studied, this is less true for renal oximetry. In our 
center, repeatability of r c SO 2 measurements revealed a 
mean difference of 4.5% (range 1–8) between three con-
secutive measurements of the same patient [Verhagen 
and Bos, unpubl. data]. Still, subtle associations between 
an HSDA and rSO 2 might not have been detected. 
 Conclusions 
 The results of our study suggest that an HSDA and ret-
rograde diastolic blood flow in the Dao do not have an 
adverse effect on cerebral and renal oxygen delivery in 
preterm infants who develop clinical signs of an HSDA 
during the first 2 weeks after birth. 
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 Table 3.  Correlation between echo parameters and NIRS measure-
ments in infants with PDA
cFTOE rFTOE rcSO2 rrSO2 CROR
Ductal diameter (mm) –0.278 –0.083 0.260 0.082 –0.040
LA:Ao ratio –0.106 –0.064 0.052 0.034 0.026
End-diastolic velocity
in LPA (m/s) –0.181 –0.418* 0.293 0.438* 0.315
EDFv/SFv DA 0.252 0.097 –0.249 –0.098 0.009
 Data are presented as Spearman’s rank order correlation coef-
ficients. cFTOE = Cerebral FTOE; rFTOE = renal FTOE; EDFv = 
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